Etilevodopa
Alternative Names: TV 1203Latest Information Update: 09 Jan 2003
At a glance
- Originator Hebrew University of Jerusalem
- Developer Lundbeck A/S; Teva Pharmaceutical Industries
- Class Antiparkinsonians; Catecholamines; Small molecules
- Mechanism of Action Dopamine receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Parkinson's disease
Most Recent Events
- 06 Jan 2003 Discontinued - Phase-II for Parkinson's disease in Israel (unspecified route)
- 06 Jan 2003 Discontinued - Phase-III for Parkinson's disease in Europe (PO)
- 06 Jan 2003 Discontinued - Phase-III for Parkinson's disease in USA (PO)